171 related articles for article (PubMed ID: 12833523)
1. Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy.
Seliger B; Menig M; Lichtenfels R; Atkins D; Bukur J; Halder TM; Kersten M; Harder A; Ackermann A; Beck J; Muehlenweg B; Brenner W; Melchior S; Kellner R; Lottspeich F
Proteomics; 2003 Jun; 3(6):979-90. PubMed ID: 12833523
[TBL] [Abstract][Full Text] [Related]
2. Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance.
Kellner R; Lichtenfels R; Atkins D; Bukur J; Ackermann A; Beck J; Brenner W; Melchior S; Seliger B
Proteomics; 2002 Dec; 2(12):1743-51. PubMed ID: 12469344
[TBL] [Abstract][Full Text] [Related]
3. Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors.
Surfus JE; Hank JA; Oosterwijk E; Welt S; Lindstrom MJ; Albertini MR; Schiller JH; Sondel PM
J Immunother Emphasis Tumor Immunol; 1996 May; 19(3):184-91. PubMed ID: 8811493
[TBL] [Abstract][Full Text] [Related]
4. Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity.
Liu Z; Smyth FE; Renner C; Lee FT; Oosterwijk E; Scott AM
Cancer Immunol Immunother; 2002 May; 51(3):171-7. PubMed ID: 11941456
[TBL] [Abstract][Full Text] [Related]
5. Parallel detection of transduced T lymphocytes after immunogene therapy of renal cell cancer by flow cytometry and real-time polymerase chain reaction: implications for loss of transgene expression.
Lamers CH; Gratama JW; Pouw NM; Langeveld SC; Krimpen BA; Kraan J; Stoter G; Debets R
Hum Gene Ther; 2005 Dec; 16(12):1452-62. PubMed ID: 16390276
[TBL] [Abstract][Full Text] [Related]
6. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
7. Beta-glucan enhanced killing of renal cell carcinoma micrometastases by monoclonal antibody G250 directed complement activation.
Sier CF; Gelderman KA; Prins FA; Gorter A
Int J Cancer; 2004 May; 109(6):900-8. PubMed ID: 15027124
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.
van Dijk J; Uemura H; Beniers AJ; Peelen WP; Zegveld ST; Fleuren GJ; Warnaar SO; Oosterwijk E
Int J Cancer; 1994 Jan; 56(2):262-8. PubMed ID: 8314310
[TBL] [Abstract][Full Text] [Related]
9. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
Li G; Passebosc-Faure K; Lambert C; Gentil-Perret A; Blanc F; Oosterwijk E; Mosnier JF; Genin C; Tostain J
Clin Cancer Res; 2001 Jan; 7(1):89-92. PubMed ID: 11205923
[TBL] [Abstract][Full Text] [Related]
10. Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma.
Unwin RD; Harnden P; Pappin D; Rahman D; Whelan P; Craven RA; Selby PJ; Banks RE
Proteomics; 2003 Jan; 3(1):45-55. PubMed ID: 12548633
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
12. Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.
Luiten RM; Coney LR; Fleuren GJ; Warnaar SO; Litvinov SV
Br J Cancer; 1996 Sep; 74(5):735-44. PubMed ID: 8795576
[TBL] [Abstract][Full Text] [Related]
13. Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses.
Lichtenfels R; Kellner R; Atkins D; Bukur J; Ackermann A; Beck J; Brenner W; Melchior S; Seliger B
Biochim Biophys Acta; 2003 Mar; 1646(1-2):21-31. PubMed ID: 12637008
[TBL] [Abstract][Full Text] [Related]
14. Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity.
van Dijk J; Zegveld ST; Fleuren GJ; Warnaar SO
Int J Cancer; 1991 Jul; 48(5):738-43. PubMed ID: 1830033
[TBL] [Abstract][Full Text] [Related]
15. Targeting of adenovirus to human renal cell carcinoma cells.
Jongmans W; van den Oudenalder K; Tiemessen DM; Molkenboer J; Willemsen R; Mulders PF; Oosterwijk E
Urology; 2003 Sep; 62(3):559-65. PubMed ID: 12946777
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeled antibodies in renal cell carcinoma.
Stillebroer AB; Oosterwijk E; Oyen WJ; Mulders PF; Boerman OC
Cancer Imaging; 2007 Nov; 7(1):179-88. PubMed ID: 18055291
[TBL] [Abstract][Full Text] [Related]
17. Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.
Brouwers AH; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
Cancer Biother Radiopharm; 2003 Aug; 18(4):539-47. PubMed ID: 14503948
[TBL] [Abstract][Full Text] [Related]
18. [Prokaryotic expression, purification and antigenicity identification of human renal cell carcinoma-associated antigen G250].
Xiao Y; Gao J; Gao K; Yan J; Zhang L; Wang Y; Xu Y; Wang W; Wang X; Yu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):269-72. PubMed ID: 23643084
[TBL] [Abstract][Full Text] [Related]
19. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis.
Klade CS; Voss T; Krystek E; Ahorn H; Zatloukal K; Pummer K; Adolf GR
Proteomics; 2001 Jul; 1(7):890-8. PubMed ID: 11503213
[TBL] [Abstract][Full Text] [Related]
20. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
Kinouchi T; Bander NH; Kotake T
J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
